Mersana Therapeutics (MRSN)
Q4 2018 Earnings Conference Call
March 08, 2019 08:00 AM ET
Company Participants
Sarah Carmody - IR and Corporate Communications
Anna Protopapas - CEO
Tim Lowinger - Chief Scientific Officer
Dave Spellman - CFO
Eva Jack - Chief Business Officer
Dirk Huebner - CMO
Conference Call Participants
Jonathan Chang - SVB Leerink
Mike Ulz - Robert W. Baird
Jessica Fye - JP Morgan
David Nierengarten - Wedbush Securities
Debjit Chattopadhyay - H.C. Wainwright
Presentation
Operator
Good morning and welcome to Mersana Therapeutics’ Fourth Quarter and Full Year 2018 Conference Call. Currently, all